Skip to main content
Equibles

CASIF · CASI Pharmaceuticals, Inc. · Share Buybacks

Track CASIF — free

Use CASIF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CASIF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.12 +0.00 (+0.00%) At close · Oct 2
Rebalance outlook locked
Market Cap
$2.26M
Shares
20.56M
Volume · Oct 2 1025 Avg daily vol (3M) 2356

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$10,000,000
as of 2021-12-15

Repurchase History

Fiscal Year Ended Cash Spent
2023-12-31 $278,000
2022-12-31 $3,267,000
Key facts CIK 1962738 CUSIP G1933S101 Visit website Investor relations